A New Strategy for Prevention of Liver Cancer Development
December 4, 2017
Overcoming Oral Oncolytic Challenges
December 5, 2017
Show all

Detecting Cognitive Decline in Multiple Sclerosis With Shortened BICAMS

There are tests to detect cognitive impairment in multiple sclerosis.

Combined administration of 2 sections of the Brief International Cognitive Assessment for multiple sclerosis (BICAMS), the symbol digit modalities test (SDMT), and brief visuospatial memory test-revised (BVMT-R), reliably detects cognitive impairment in patients with multiple sclerosis (MS) in a more time-efficient manner than administering the whole BICAMS, according to findings presented at the 7th Joint ECTRIMS-ACTRIMS Meeting, held October 25-28, 2017 in Paris.

“The screening tool [BICAMS] was proposed as an international instrument to homogenize cognitive assessment across countries,” the researchers wrote. With its 20-[minute] application time, it is one of the few tools available to be implemented even in small [centers] with only [a] few staff members who might not be particularly trained in administering neuropsychological tests.”

When applying the full BICAMS battery, 41.7% of screened patients had cognitive impairment. The combined SDMT and BVMT-R tests (93.0%, P =.002) and the VLMT and BVMT-R (93.6%, P<.001) had a significantly higher consistency with the total BICAMS battery compared with the combined SDMT and VLMT tests (89.5%). All combinations of two tests were more consistent with the full BICAMS battery than single tests alone.

Read full article: Detecting Cognitive Decline in Multiple Sclerosis With Shortened BICAMS

Read Full Article: Detecting Cognitive Decline in Multiple Sclerosis With Shortened BICAMS

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.